Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00287118
Status:
COMPLETED
Last Update Posted:
2018-04-03
First Post:
2006-02-02
Brief Title:
A Multicentre Open Label Phase IIIbIV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis
Sponsor:
Organization:
Merck KGaA Darmstadt Germany